Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS

Conclusion:</b> Dosage cumulative doxorubicin ranges between 47.93 and 346.09 mg/m<sup>2</sup>; with this, the risk of cardiomyopathy in the patients surveyed is under 4%, according to the literature.PMID:38686734 | DOI:10.3923/pjbs.2024.125.131

Source: Pakistan Journal of Biological Sciences: PJBS - April 30, 2024 Category: Biomedical Science Authors: Dian Fitri Chairunnisa Yahdiana Harahap Maria Juanita Nadia Farhanah Syafhan Denni Joko Purwanto Source Type: research